Inequities in Treatments and Outcomes Among Patients Hospitalized With Hypertrophic Cardiomyopathy in the United States

被引:4
作者
Johnson, Daniel Y. [1 ]
Waken, R. J. [1 ]
Fox, Daniel K. [1 ]
Hammond, Gmerice [1 ]
Maddox, Karen E. Joynt E. [1 ,2 ]
Cresci, Sharon [1 ,3 ,4 ]
机构
[1] Washington Univ Sch Med, Dept Med, Cardiovasc Div, St Louis, MO USA
[2] Washington Univ, Ctr Hlth Econ & Policy, Inst Publ Hlth, St Louis, MO USA
[3] Washington Univ, Dept Genet, Sch Med, St Louis, MO USA
[4] Washington Univ, Sch Med, 660 South Euclid Ave,Box 8086, St Louis, MO 63130 USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2023年 / 12卷 / 11期
基金
美国国家卫生研究院;
关键词
disparities; ethnicity; hypertrophic cardiomyopathy; outcomes; race; sex; ASSOCIATION; MANAGEMENT; MORTALITY; ABLATION; HEALTH; RACE;
D O I
10.1161/JAHA.122.029930
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundHypertrophic cardiomyopathy (HCM) is the most common heritable cardiac disease. In small studies, sociodemographic factors have been associated with disparities in septal reduction therapy, but little is known about the association of sociodemographic factors with HCM treatments and outcomes more broadly. Methods and ResultsUsing the National Inpatient Survey from 2012 to 2018, HCM diagnoses and procedures were identified by International Classification of Diseases, Ninth/Tenth Revision, Clinical Modification (ICD-9-CM and ICD-10-CM) codes. Logistic regression was used to determine the association of sociodemographic risk factors with HCM procedures and in-hospital death, adjusting for clinical comorbidities and hospital characteristics. Of 53 117 patients hospitalized with HCM, 57.7% were women, 20.5% were Black individuals, 27.7% lived in the lowest zip income quartile, and 14.7% lived in rural areas. Among those with obstruction (45.2%), compared with White patients, Black patients were less likely to undergo septal myectomy (adjusted odds ratio [aOR], 0.52 [95% CI, 0.40-0.68]), or alcohol septal ablation (aOR, 0.60 [95% CI, 0.42-0.86]). Patients with Medicaid were less likely to undergo each procedure (aOR, 0.78 [95% CI, 0.61-0.99] for myectomy; aOR, 0.54 [95% CI, 0.36-0.83] for ablation). Women (aOR, 0.66 [95% CI, 0.58-0.74]), patients with Medicaid (aOR, 0.78 [95% CI, 0.65-0.93]), and patients from low-income areas (aOR, 0.77 [95% CI, 0.65-0.93]) were less likely to receive implantable cardioverter-defibrillators. Women (aOR, 1.23 [95% CI, 1.10-1.37]) and patients from towns (aOR, 1.16 [95% CI, 1.03-1.31]) or rural areas (aOR, 1.57 [95% CI, 1.30-1.89]) had higher odds of in-hospital death. ConclusionsAmong 53 117 patients hospitalized with HCM, race, sex, social, and geographic risk factors were associated with disparities in HCM outcomes and treatment. Further research is required to identify and address the sources of these inequities.
引用
收藏
页数:16
相关论文
共 29 条
[1]  
[Anonymous], 2021, Healthcare cost and Utilization Project
[2]   Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy [J].
Arabadjian, Milla E. ;
Yu, Gary ;
Sherrid, Mark, V ;
Dickson, Victoria Vaughan .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (17)
[3]   Gender Disparity in a Large Nonreferral-Based Cohort of Hypertrophic Cardiomyopathy Patients [J].
Brimacombe, M. ;
Walter, D. ;
Salberg, L. .
JOURNAL OF WOMENS HEALTH, 2008, 17 (10) :1629-1634
[4]   Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment [J].
Butters, Alexandra ;
Lakdawala, Neal K. ;
Ingles, Jodie .
CURRENT HEART FAILURE REPORTS, 2021, 18 (05) :264-273
[5]   Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy [J].
Eberly, Lauren A. ;
Day, Sharlene M. ;
Ashley, Euan A. ;
Jacoby, Daniel L. ;
Jefferies, John Lynn ;
Colan, Steven D. ;
Rossano, Joseph W. ;
Semsarian, Christopher ;
Pereira, Alexandre C. ;
Olivotto, Iacopo ;
Ingles, Jodie ;
Seidman, Christine E. ;
Channaoui, Nadine ;
Cirino, Allison L. ;
Han, Larry ;
Ho, Carolyn Y. ;
Lakdawala, Neal K. .
JAMA CARDIOLOGY, 2020, 5 (01) :83-91
[6]   The Impact of Syndromic Genetic Disorders on Medical Management and Mortality in Pediatric Hypertrophic Cardiomyopathy Patients [J].
Edelson, Jonathan B. ;
Griffis, Heather ;
Burstein, Danielle S. ;
Zhang, Xuemei ;
Rossano, Joseph W. ;
Lin, Kimberly Y. ;
O'Connor, Matthew J. .
PEDIATRIC CARDIOLOGY, 2020, 41 (06) :1180-1189
[7]   Comorbidity measures for use with administrative data [J].
Elixhauser, A ;
Steiner, C ;
Harris, DR ;
Coffey, RN .
MEDICAL CARE, 1998, 36 (01) :8-27
[8]   Women with hypertrophic cardiomyopathy have worse survival [J].
Geske, Jeffrey B. ;
Ong, Kevin C. ;
Siontis, Konstantinos C. ;
Hebl, Virginia B. ;
Ackerman, Michael J. ;
Hodge, David O. ;
Miller, Virginia M. ;
Nishimura, Rick A. ;
Oh, Jae K. ;
Schaff, Hartzell V. ;
Gersh, Bernard J. ;
Ommen, Steve R. .
EUROPEAN HEART JOURNAL, 2017, 38 (46) :3434-U20
[9]   Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association [J].
Harrington, Robert A. ;
Califf, Robert M. ;
Balamurugan, Appathurai ;
Brown, Nancy ;
Benjamin, Regina M. ;
Braund, Wendy E. ;
Hipp, Janie ;
Konig, Madeleine ;
Sanchez, Eduardo ;
Maddox, Karen E. Joynt .
CIRCULATION, 2020, 141 (10) :E615-E644
[10]  
Heradien M, 2007, Cardiovasc J Afr, V18, P312